Skip to content

Homeopathic medicines for knee pain

An open-label, Randomized, Placebo-controlled Trial to Evaluate the Efficacy of Osteo-arthritis nosode and Individualized Homoeopathic Medicines in Osteoarthritis of knee

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021670
Enrollment
111
Registered
2019-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Osteo-arthritis nosode in centesimal potencies: Osteo-arthritis nosode in centesimal potencies, as decided appropriate to the case or condition. In centesimal scale, each dose shall con
dosage and repetition depending upon the individual requirement of the cases. The medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. General management will include ic

Sponsors

D N De Homoeopathic Medical College Hospital Govt of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 35-70 years 2. Both sexes 3. Diagnosed knee osteoarthritis as per American College of Rheumatology (ACR) clinical/radiographic classification criteria: a) Knee pain b) At least 1 of 3: age more than 50 years, stiffness less than 30 min, and crepitus on knee motion c) Osteophytes on knee x-ray 4. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of osteoarthritis, provided the medications are stopped completely at least 2 weeks prior study entry 5. Literate patients; can read Bengali, Hindi or English 6. Providing written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe degeneration of knee joint with marked joint narrowing, varus, or valgus deformity of knee ( >12°), evidenced by imaging or other evidences and requiring surgical intervention 2. Non-ambulant patients 3. Self-reported joint disorders other than osteoarthritis (e.g., inflammatory joint disease, specific arthropathy, hyperuricaemia and/or gout, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) 4. Intra-articular injections within 2 weeks before study entry 5. Transplanted knees 6. Recent significant knee surgery within last 6 months 7. Patients who are too sick for consultation 8. Unwilling to take part and not giving consent to join the study 9. Unable to read patient information sheet 10. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 11. Pregnancy and lactation 12. Substance abuse and/or dependence 13. Self-reported immune-compromised state, and 14. Undergoing homeopathic treatment for any chronic disease within last 6 months

Design outcomes

Primary

MeasureTime frame
Knee injury and Osteoarthritis Outcome Score (KOOS)Timepoint: At baseline, every month up to 3 months

Secondary

MeasureTime frame
EQ-5D-5L questionnaireTimepoint: At baseline, every month up to 3 months;Frequency of add-on Paracetamol and/or NSAIDs (oral/topical) useTimepoint: At baseline, every month up to 3 months

Countries

India

Contacts

Public ContactShyamal Kumar Mukherjee

D. N. De Homoeopathic Medical College & Hospital, Govt. of West Bengal

shyamalmukhergee@gmail.com9831113383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026